Skip to Content

Urokinase Pregnancy and Breastfeeding Warnings

Urokinase is also known as: Abbokinase, Abbokinase Open-Cath, Kinlytic

Urokinase Pregnancy Warnings

This drug should be used during pregnancy only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Urokinase Breastfeeding Warnings

Caution is recommended; some authorities recommend avoiding breastfeeding during use of this drug.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Kinlytic (urokinase)." ImaRx Therapeutics, Inc, Tucson,, AR.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. "Product Information. Kinlytic (urokinase)." ImaRx Therapeutics, Inc, Tucson,, AR.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide